Crosstalk between astrocytes and motor neurons: What is the message?

Experimental Neurology

Volumn 211, Issue 1, 2008, Pages 1-6

  Van Den Bosch, L ^a   Robberecht, W ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

AMPA receptor; Amyotrophic lateral sclerosis; Excitotoxicity; Neurotrophic factor; Oxidative stress

Indexed keywords

GLUTAMIC ACID; GROWTH FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL SURVIVAL; MOTONEURON; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 42749097816     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.01.008     Document Type: Note

References (63)

1. Bendotti C. Tortarolo M. Suchak S.K. Calvaresi N. Carvelli L. Bastone A. Rizzi M. Rattray M. Mennini T. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels J. Neurochem. 79 2001 737 746
2. Bensimon G. Lacomblez L. Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole. Study. Group N. Engl. J. Med. 330 1994 585 591
3. Boillee S. Vande Velde C. Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors Neuron 52 2006 39 59
4. Boillee S. Yamanaka K. Lobsiger C.S. Copeland N.G. Jenkins N.A. Kassiotis G. Kollias G. Cleveland D.W. Onset and progression in inherited ALS determined by motor neurons and microglia Science 312 2006 1389 1392
5. Bruijn L.I. Becher M.W. Lee M.K. Anderson K.L. Jenkins N.A. Copeland N.G. Sisodia S.S. Rothstein J.D. Borchelt D.R. Price D.L. Cleveland D.W. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions Neuron 18 1997 327 338
6. Canton T. Bohme G.A. Boireau A. Bordier F. Mignani S. Jimonet P. Jahn G. Alavijeh M. Stygall J. Roberts S. Brealey C. Vuilhorgne M. Debono M.W. Le Guern S. Laville M. Briet D. Roux M. Stutzmann J.M. Pratt J. RPR 119990, a novel α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis J. Pharmacol. Exp. Ther. 299 2001 314 322
7. Carriedo S.G. Yin H.Z. Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro J. Neurosci. 16 1996 4069 4079
8. 2+ overload and ROS generation in spinal motor neurons in vitro J. Neurosci. 20 2000 240 250
9. Clement A.M. Nguyen M.D. Roberts E.A. Garcia M.L. Boillee S. Rule M. McMahon A.P. Doucette W. Siwek D. Ferrante R.J. Brown R.H. Jr. Julien J.P. Goldstein L.S. Cleveland D.W. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice Science 302 2003 113 117
10. Cudkowicz M.E. Shefner J.M. Schoenfeld D.A. Brown R.H. Jr. Johnson H. Qureshi M. Jacobs M. Rothstein J.D. Appel S.H. Pascuzzi R.M. Heiman-Patterson T.D. Donofrio P.D. David W.S. Russell J.A. Tandan R. Pioro E.P. Felice K.J. Rosenfeld J. Mandler R.N. Sachs G.M. Bradley W.G. Raynor E.M. Baquis G.D. Belsh J.M. Novella S. Goldstein J. Hulihan J. A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis Neurology 61 2003 456 464
11. Dewil M. Lambrechts D. Sciot R. Shaw P.J. Ince P.G. Robberecht W. Van Den Bosch L. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis Neuropathol. Appl. Neurobiol. 33 2007 499 509
12. Di Giorgio F.P. Carrasco M.A. Siao M.C. Maniatis T. Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model Nat. Neurosci. 10 2007 608 614
13. Eisen A. Stewart H. Schulzer M. Cameron D. Anti-glutamate therapy in amyotrophic lateral sclerosis: a trial using lamotrigine Can. J. Neurol. Sci. 20 1993 297 301
14. Ekestern E. Neurotrophic factors and amyotrophic lateral sclerosis Neurodegener. Dis. 1 2004 88 100
15. Fray A.E. Ince P.G. Banner S.J. Milton I.D. Usher P.A. Cookson M.R. Shaw P.J. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study Eur. J. Neurosci. 10 1998 2481 2489
16. Ghadge G.D. Slusher B.S. Bodner A. Canto M.D. Wozniak K. Thomas A.G. Rojas C. Tsukamoto T. Majer P. Miller R.J. Monti A.L. Roos R.P. Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models Proc. Natl. Acad. Sci. U. S. A. 100 2003 9554 9559
17. Gong Y.H. Parsadanian A.S. Andreeva A. Snider W.D. Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration J. Neurosci. 20 2000 660 665
18. 2+ transients in cultured spinal motor neurons Cell. Calcium. 42 2007 59 69
19. Guo H. Lai L. Butchbach M.E. Stockinger M.P. Shan X. Bishop G.A. Lin C.L. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice Hum. Mol. Genet. 12 2003 2519 2532
20. Gurney M.E. Cutting F.B. Zhai P. Doble A. Taylor C.P. Andrus P.K. Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis Ann. Neurol. 39 1996 147 157
21. Gurney M.E. Pu H. Chiu A.Y. Dal Canto M.C. Polchow C.Y. Alexander D.D. Caliendo J. Hentati A. Kwon Y.W. Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 264 1994 1772 1775
22. Hall E.D. Oostveen J.A. Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS Glia 23 1998 249 256
23. Howland D.S. Liu J. She Y. Goad B. Maragakis N.J. Kim B. Erickson J. Kulik J. DeVito L. Psaltis G. DeGennaro L.J. Cleveland D.W. Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. U. S. A. 99 2002 1604 1609
24. Jones, T., 1999. An assessment of the efficacy and safety of LY300164 in patients with ALS/MND. Abstract ALS/MND.
25. Kriz J. Nguyen M.D. Julien J.P. Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis Neurobiol. Dis. 10 2002 268 278
26. Kushner P.D. Stephenson D.T. Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain J. Neuropathol. Exp. Neurol. 50 1991 263 277
27. Lacomblez L. Bensimon G. Leigh P.N. Guillet P. Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II Lancet 347 1996 1425 1431
28. Lino M.M. Schneider C. Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease J. Neurosci. 22 2002 4825 4832
29. Mazzini L. Mora G. Balzarini C. Brigatti M. Pirali I. Comazzi F. Pastore E. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis J. Neurol. Sci. 160. Suppl. 1 1998 S57 S63
30. Miller R.G. Moore D. Young L.A. Armon C. Barohn R.J. Bromberg M.B. Bryan W.W. Gelinas D.F. Mendoza M.C. Neville H.E. Parry G.J. Petajan J.H. Ravits J.M. Ringel S.P. Ross M.A. Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group Neurology 47 1996 1383 1388
31. Miller R.G. Moore D.H. 2nd Gelinas D.F. Dronsky V. Mendoza M. Barohn R.J. Bryan W. Ravits J. Yuen E. Neville H. Ringel S. Bromberg M. Petajan J. Amato A.A. Jackson C. Johnson W. Mandler R. Bosch P. Smith B. Graves M. Ross M. Sorenson E.J. Kelkar P. Parry G. Olney R. Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis Neurology 56 2001 843 848
32. Nagai M. Re D.B. Nagata T. Chalazonitis A. Jessell T.M. Wichterle H. Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons Nat. Neurosci. 10 2007 615 622
33. Nagano I. Ilieva H. Shiote M. Murakami T. Yokoyama M. Shoji M. Abe K. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis J. Neurol. Sci. 235 2005 61 68
34. Oosthuyse B. Moons L. Storkebaum E. Beck H. Nuyens D. Brusselmans K. Van Dorpe J. Hellings P. Gorselink M. Heymans S. Theilmeier G. Dewerchin M. Laudenbach V. Vermylen P. Raat H. Acker T. Vleminckx V. Van Den Bosch L. Cashman N. Fujisawa H. Drost M.R. Sciot R. Bruyninckx F. Hicklin D.J. Ince C. Gressens P. Lupu F. Plate K.H. Robberecht W. Herbert J.M. Collen D. Carmeliet P. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nat. Genet. 28 2001 131 138
35. Palecek J. Lips M.B. Keller B.U. Calcium dynamics and buffering in motoneurones of the mouse spinal cord J. Physiol. 520 Pt 2 1999 485 502 520. Pt
36. Pehar M. Cassina P. Vargas M.R. Castellanos R. Viera L. Beckman J.S. Estevez A.G. Barbeito L. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis J. Neurochem. 89 2004 464 473
37. Pramatarova A. Laganiere J. Roussel J. Brisebois K. Rouleau G. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment J. Neurosci. 21 2001 3369 3374
38. Rao C.V. Weiss J.H. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis Trends Neurosci. 27 2004 17 23
39. Rao S.D. Yin H.Z. Weiss J.H. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons J. Neurosci. 23 2003 2627 2633
40. Rosen D.R. Siddique T. Patterson D. Figlewicz D.A. Sapp P. Hentati A. Donaldson D. Goto J. O'Regan J.P. Deng H.X. Rahmani Z. Krizus A. McKenna-Yasek D. Cayabyab A. Gaston S.M. Berger R. Tanzi R.E. Halperin J.J. Herzfeldt B. Van den Bergh R. Hung W.Y. Bird T. Deng G. Mulder D.W. Smyth C. Laing N.G. Soriano E. Pericak-Vance M.A. Haines J. Rouleau G.A. Gusella J.S. Horvitz H.R. Brown R.H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
41. Rothstein J.D. Martin L.J. Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis N. Engl. J. Med. 326 1992 1464 1468
42. Rothstein J.D. Van Kammen M. Levey A.I. Martin L.J. Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann. Neurol. 38 1995 73 84
43. Rothstein J.D. Dykes-Hoberg M. Pardo C.A. Bristol L.A. Jin L. Kuncl R.W. Kanai Y. Hediger M.A. Wang Y. Schielke J.P. Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate Neuron. 16 1996 675 686
44. Rothstein J.D. Patel S. Regan M.R. Haenggeli C. Huang Y.H. Bergles D.E. Jin L. Dykes-Hoberg M. Vidensky S. Chung D.S. Toan S.V. Bruijn L.I. Su Z.Z. Gupta P. Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression Nature 433 2005 73 77
45. Sasaki S. Komori T. Iwata M. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis Acta Neuropathol. (Berl). 100 2000 138 144
46. 3H] d -aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study Brain. Res. 655 1994 195 201
47. Storkebaum E. Lambrechts D. Dewerchin M. Moreno-Murciano M.P. Appelmans S. Oh H. Van Damme P. Rutten B. Man W.Y. De Mol M. Wyns S. Manka D. Vermeulen K. Van Den Bosch L. Mertens N. Schmitz C. Robberecht W. Conway E.M. Collen D. Moons L. Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS Nat. Neurosci. 8 2005 85 92
48. Tateno M. Sadakata H. Tanaka M. Itohara S. Shin R.M. Miura M. Masuda M. Aosaki T. Urushitani M. Misawa H. Takahashi R. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model Hum. Mol. Genet. 13 2004 2183 2196
49. Tortarolo M. Grignaschi G. Calvaresi N. Zennaro E. Spaltro G. Colovic M. Fracasso C. Guiso G. Elger B. Schneider H. Seilheimer B. Caccia S. Bendotti C. Glutamate AMPA receptors change in motor neurons of SOD1(G93A) transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amyotrophic lateral sclerosis-like disease J. Neurosci. Res. 83 2006 134 146
50. Traynor B.J. Bruijn L. Conwit R. Beal F. O'Neill G. Fagan S.C. Cudkowicz M.E. Neuroprotective agents for clinical trials in ALS: a systematic assessment Neurology 67 2006 20 27
51. Trotti D. Rolfs A. Danbolt N.C. Brown R.H. Jr. Hediger M.A. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter Nat. Neurosci. 2 1999 427 433
52. Urushitani M. Sik A. Sakurai T. Nukina N. Takahashi R. Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis Nat. Neurosci. 9 2006 108 118
53. Van Damme P. Leyssen M. Callewaert G. Robberecht W. Van Den Bosch L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis Neurosci. Lett. 343 2003 81 84
54. Van Damme P. Braeken D. Callewaert G. Robberecht W. Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 64 2005 605 612
55. Van Damme P. Bogaert E. Dewil M. Hersmus N. Kiraly D. Scheveneels W. Bockx I. Braeken D. Verpoorten N. Verhoeven K. Timmerman V. Herijgers P. Callewaert G. Carmeliet P. Van Den Bosch L. Robberecht W. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity Proc. Natl. Acad. Sci. U. S. A. 104 2007 14825 14830
56. 2+-permeable AMPA receptors and selective vulnerability of motor neurons J. Neurol. Sci. 180 2000 29 34
57. Van Den Bosch L. Tilkin P. Lemmens G. Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS Neuroreport 13 2002 1067 1070
58. 2+ influx and not via calpain inhibition Neuropharmacology 42 2002 706 713
59. Van Den Bosch L. Storkebaum E. Vleminckx V. Moons L. Vanopdenbosch L. Scheveneels W. Carmeliet P. Robberecht W. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration Neurobiol. Dis. 17 2004 21 28
60. Van Den Bosch L. Van Damme P. Bogaert E. Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis Biochim. Biophys. Acta 1762 2006 1068 1082
61. Vandenberghe W. Van Den Bosch L. Robberecht W. Glial cells potentiate kainate-induced neuronal death in a motoneuron-enriched spinal coculture system Brain. Res. 807 1998 1 10
62. Yamanaka, K., Chun, S.J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D.H., Takahashi, R., Misawa, H., Cleveland, D.W., in press. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. (published online 3 February 2008). doi:10.1038/nn2047 .
63. Yin H.Z. Tang D.T. Weiss J.H. Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS Exp. Neurol. 207 2007 177 185